|
|
Volumn 6, Issue 7, 2000, Pages 723-724
|
|
Industry outlines its perspective on new Third-World vaccine development
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BCG VACCINE;
HAEMOPHILUS INFLUENZAE TYPE B VACCINE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
MALARIA VACCINE;
DRUG INDUSTRY;
DRUG RESEARCH;
HEALTH CARE ORGANIZATION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALARIA;
NOTE;
PRIORITY JOURNAL;
TUBERCULOSIS;
VACCINE PRODUCTION;
WORLD HEALTH ORGANIZATION;
HAEMOPHILUS;
HAEMOPHILUS INFLUENZAE SEROTYPE B;
HUMAN IMMUNODEFICIENCY VIRUS;
MYCOBACTERIUM BOVIS BCG;
|
|
EID: 0033942249
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/77417 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|